Related Experiment Video
Updated: Feb 1, 2026

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
Published on: May 24, 2016
Loss of miR-155 upregulates WEE1 in metastatic melanoma
Julie A DiSano1, Ian Huffnagle1, Raghavendra Gowda2
1Department of Surgery, Division of General Surgery Subspecialties and Surgical Oncology.
Abstract:
Significant advances have been made in the treatment of melanoma by targeting key cellular pathways, but additional targets are needed as many patients do not respond or relapse with resistant disease. MicroRNA-155 (MiR-155) has previously been shown to regulate melanoma cell growth and acts as a tumor suppressor. We tested a clinical population of melanoma tumors for miR-155 expression, and find that expression is low in most patients, although not predictive of outcome. We identified the protein kinase WEE1 as a novel target of miR-155. A mouse model of experimental metastasis finds that both increased expression of miR-155 and silencing of WEE1 lead to decreased metastases. Loss of miR-155 and increased expression of WEE1 may contribute to the metastatic phenotype in patients with melanoma.
Insights
MicroRNA-155 (miR-155) acts as a tumor suppressor in melanoma. Lower miR-155 and higher WEE1 expression correlate with increased melanoma metastasis, suggesting new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma treatment advances target cellular pathways, yet resistance and non-response necessitate novel therapeutic targets.
- MicroRNA-155 (miR-155) is implicated in regulating melanoma cell growth, with prior studies suggesting a tumor-suppressive role.
- Identifying new molecular targets is crucial for overcoming therapeutic resistance in melanoma patients.
Purpose of the Study:
- To investigate the expression of miR-155 in a clinical melanoma patient cohort.
- To identify novel molecular targets regulated by miR-155 in melanoma.
- To evaluate the therapeutic potential of modulating miR-155 and its targets in melanoma metastasis.
Main Methods:
- Quantitative analysis of miR-155 expression in clinical melanoma tumor samples.
- Identification of protein targets of miR-155 using molecular biology techniques.
- Assessment of melanoma metastasis in a preclinical mouse model following manipulation of miR-155 and WEE1 expression.
Main Results:
- Low miR-155 expression was observed in a majority of melanoma patients, though not directly predictive of clinical outcome.
- Protein kinase WEE1 was identified as a direct and novel target of miR-155 regulation.
- Experimental metastasis assays in mice demonstrated that increased miR-155 or WEE1 silencing significantly reduced metastatic burden.
Conclusions:
- Loss of miR-155 and concurrent upregulation of WEE1 may drive melanoma progression and metastasis.
- Targeting the miR-155/WEE1 axis presents a promising therapeutic strategy for managing metastatic melanoma.
- Further research into miR-155 and WEE1 could lead to improved treatment outcomes for melanoma patients.
Related Concept Videos
Line Loss
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Energy Losses in Transformers
There are four main reasons for energy losses in transformers.
The first cause can be the high resistance of the...
Major Losses in Pipes
Fluid flow can be classified as laminar or turbulent, primarily based on the Reynolds number. This dimensionless number reflects the relative influence of inertial to viscous...
Minor Losses in Pipes
Valves play a significant role in generating minor losses by obstructing or redirecting the fluid flow. When a valve is closed or partially closed, it restricts the flow...
Adaptations that Reduce Water Loss

